P.A.W. CAPITAL CORP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
P.A.W. CAPITAL CORP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$838,000
+5.0%
250,000
-16.7%
0.83%
-17.2%
Q4 2018$798,000
-43.0%
300,000
+20.0%
1.00%
-32.6%
Q3 2018$1,400,000250,0001.49%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 1,360,000$6,895,0005.06%
Omega Fund Management, LLC 778,230$3,946,0002.91%
BVF INC/IL 5,346,838$27,108,0002.65%
Virtus ETF Advisers LLC 152,550$773,0000.68%
SPHERA FUNDS MANAGEMENT LTD. 842,632$4,272,0000.59%
Tekla Capital Management LLC 2,087,380$10,583,0000.40%
Schonfeld Strategic Advisors LLC 828,600$4,201,0000.23%
Orbimed Advisors 3,140,000$15,920,0000.19%
Lombard Odier Asset Management (USA) Corp 563,878$2,859,0000.19%
Rhenman & Partners Asset Management AB 300,000$1,521,0000.16%
View complete list of PIERIS PHARMACEUTICALS INC shareholders